利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

7 条记录 (耗时 0.034 秒)

    Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    3.
    发明申请
    Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists 审中-公开
    取代的氮杂双环己烷衍生物作为毒蕈碱受体拮抗剂

    公开(公告)号：US20070010568A1

    公开(公告)日：2007-01-11

    申请号：US10544520

    申请日：2003-02-07

    申请人： Anita Mehta ,  Bruhaspathy Miriyala ,  Naresh Kumar ,  Jang Gupta

    发明人： Anita Mehta ,  Bruhaspathy Miriyala ,  Naresh Kumar ,  Jang Gupta

    IPC分类号： A61K31/403 ,  C07D209/02

    CPC分类号： C07D471/08

    摘要： This invention relates to derivatives of substituted azabicyclo hexanes. The compound of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.

    摘要翻译： 本发明涉及取代的氮杂双环己烷的衍生物。 本发明化合物可用作毒蕈碱受体拮抗剂，可用于治疗通过毒蕈碱受体介导的呼吸道，尿路和胃肠道系统的各种疾病。 本发明还涉及制备本发明化合物的方法，含有本发明化合物的药物组合物以及通过毒蕈碱受体介导的疾病的治疗方法。

    3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    4.
    发明申请
    3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists 失效
    3,6-二取代的氮杂双环己烷衍生物作为毒蕈碱受体拮抗剂

    公开(公告)号：US20070135508A1

    公开(公告)日：2007-06-14

    申请号：US10552502

    申请日：2003-04-10

    申请人： Anita Mehta ,  Bruhaspathy Miriyala ,  Arundutt Silamkoti ,  Jang Gupta

    发明人： Anita Mehta ,  Bruhaspathy Miriyala ,  Arundutt Silamkoti ,  Jang Gupta

    IPC分类号： A61K31/403 ,  C07D405/02

    CPC分类号： C07D209/52

    摘要： The present invention relates to a radio telephony network (1) supporting at least one link of a radio channel (6) for a packet data transmission service. The radio telephony network (1) comprises a plurality of network controllers (RNC). Each network controller (RNC) is connected, via an interface Iub, to at least one base radio station (B-node) supervising at least one macrocell (5a). The radio telephony network (1) additionally comprises at least one base radio microstation (B1-micronode) connected to the network controller (RNC) via an interface Iub of the same type as that connecting the base radio station (B-node) to said controller. The base radio microstation (B1 micronode) supervises at least one microcell (5b) incorporated in at least one macrocell (5a). The base radio microstation (B1-micronode) provides the packet data transmission service in the microcell (5b) on the link of the radio channel (6).

    摘要翻译： 本发明涉及支持用于分组数据传输服务的无线电信道（6）的至少一个链路的无线电电话网络（1）。 无线电电话网络（1）包括多个网络控制器（RNC）。 每个网络控制器（RNC）经由接口Iub连接到监督至少一个宏小区（5a）的至少一个基站无线电台（B节点）。 无线电电话网络（1）还包括经由与将基站无线电台（B节点）连接到所述网络控制器（RNC）的相同类型的接口Iub连接到网络控制器（RNC）的至少一个基站无线电微站（B1微米） 控制器。 基站无线电微型站（B1微处理器）监督并入至少一个宏小区（5a）中的至少一个微小区（5b）。 基站无线电微站（B1-micronode）在无线电信道（6）的链路上的微小区（5b）中提供分组数据传输服务。

    Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    6.
    发明授权
    Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists 失效
    取代的氮杂双环己烷衍生物作为毒蕈碱受体拮抗剂

    公开(公告)号：US07517905B2

    公开(公告)日：2009-04-14

    申请号：US10552456

    申请日：2003-04-09

    申请人： Anita Mehta ,  Bruhaspathy Miriyala ,  Sudershan Kumar Arora ,  Jang Bahadur Gupta

    发明人： Anita Mehta ,  Bruhaspathy Miriyala ,  Sudershan Kumar Arora ,  Jang Bahadur Gupta

    IPC分类号： A61K31/403 ,  C07D209/52

    CPC分类号： C07D209/52

    摘要： This invention relates to the derivatives of substituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of the compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.

    摘要翻译： 本发明涉及取代的氮杂双环己烷的衍生物。 本发明的化合物可用作毒蕈碱受体拮抗剂，可用于治疗通过毒蕈碱受体介导的呼吸，泌尿和胃肠系统的各种疾病。 本发明还涉及制备本发明化合物的方法，含有本发明化合物的药物组合物和通过毒蕈碱受体介导的疾病的治疗方法。